Top compounds associated with response to LYSMD1


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.6
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC 0.031 0.6
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC 0.039 0.6
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.02 0.6
mRNA Bortezomib gCSI pan-cancer AAC 0.031 0.6
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.02 0.6
mRNA ML258 CTRPv2 pan-cancer AAC 0.02 0.6
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.02 0.6
mRNA nintedanib CTRPv2 pan-cancer AAC -0.019 0.6
Download CSV